Age Management Medicine Group

March 07, 2016 16:00 ET

Confronting Testosterone Therapy Controversies -- Noted Featured Speaker Dr. Abraham Morgentaler Presents Nine Medical Expert Resolutions at Age Management Medicine Conference in May

The Four-Day, CME-Accredited Conference -- Presented by the Age Management Medicine Group (AMMG) -- Will Be Held at the Omni Hotel & Resort in ChampionsGate/Orlando, Florida, May 12-15

NAPLES, FL--(Marketwired - March 07, 2016) - Testosterone therapy continues to be a hotbed of controversy in the media and among medical experts. On May 13, the veil will be lifted when featured speaker Dr. Abraham Morgentaler takes the platform at the 20th Clinical Applications for Age Management Medicine Conference in Florida to present nine resolutions-from 18 experts representing 11 countries and the disciplines of urology, endocrinology, andrology, diabetology and basic science research-which address key scientific issues about testosterone deficiency and testosterone therapy that are misunderstood or distorted in the press.

Morgentaler -- author of "Testosterone for Life" and "The Truth about Men and Sex" -- is an Associate Clinical Professor of Urology at Harvard Medical School, and Director/ Founder of Men's Health Boston, the first center in the US to focus on the special healthcare needs of men, which opened in 1995.

"I'm delighted to bring the latest information from around the world to the AMMG conference, regarding testosterone therapy. I think attendees will find both of my presentations illuminating, scientifically, and of considerable practical value in their own practice," said Morgentaler.

Per Morgentaler, the nine resolutions were the result of an international expert consensus conference, held in Prague on October 1, 2015. The panel's focus included such items as...

  • the importance of testosterone deficiency
  • the global impact of testosterone deficiency
  • the validity of age-specific restrictions on the use of testosterone
  • does it make sense for testosterone to be only used in men with an identified medical condition
  • is there really a risk of prostate cancer or evidence of cardiovascular disease risk with testosterone use

"When Dr. Morgentaler presents, the audience is always enthralled with him. He's leading the charge on testosterone therapy, especially now with his nine expert resolutions, as well as his additional presentation that same day, regarding the role of testosterone therapy in patients with active prostate cancer. Dr. Morgentaler clearly is the right man for the right time, talking about the right topic," said Greg Fillmore, Conference Chairman/Cofounder of the Age Management Medicine Group (AMMG).

AMMG's four-day conference offers physicians and healthcare professionals a dynamic academic curriculum to learn proactive, integrative protocols and emerging science to optimize health, as well as earn 26 AMA PRA Category 1 CME Credits. Registration for the event is available online.

For more information about AMMG or the 20th Clinical Applications in Age Management Medicine Conference, visit

About Age Management Medicine Group

The Age Management Medicine Group (AMMG) -- led by Executive Director/ Cofounder Rick Merner and Conference Chairman/Cofounder Greg Fillmore -- provides education and information to physicians and healthcare professionals on age management medicine, a proactive medical approach for optimized health and the delay/prevention of age-related disease. Education is presented through evidence-based, continuing medical education conferences, workshops, seminars, publications and web media. AMMG membership consists of leading healthcare professionals, physicians, practitioners, researchers, medical associations as well as product and service providers.

Contact Information